A retrospective study on comparison of clinical characteristics and outcomes of diabetic ketoacidosis patients with and without acute pancreatitis.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
16 03 2023
16 03 2023
Historique:
received:
12
11
2022
accepted:
13
03
2023
entrez:
17
3
2023
pubmed:
18
3
2023
medline:
22
3
2023
Statut:
epublish
Résumé
The co-existence of diabetic ketoacidosis (DKA) with acute pancreatitis (AP) is associated with unfavorable clinical outcomes. However, diagnosing AP in DKA patients is challenging and often missed due to overlapping symptoms. The aim of this retrospective observational study was to compare the clinical characteristics and outcomes of patients with concomitant DKA and AP or DKA alone. Data of patients with DKA admitted between January 2015 to August 2021 to four hospitals in Qatar was extracted from the electronic health record (Cerner). American Diabetes Association criteria and Atlanta criteria were used for DKA and AP diagnosis, respectively. Independent T-test or Mann-Whitney U test was used to analyze continuous variables, whereas categorical variables were analyzed via Chi-square or Fischer exact tests as appropriate. Univariate and multivariate logistic regression models were generated to assess the correlations. A p-value of < 0.05 was considered statistically significant. Of 936 patients with DKA, 84 (9.0%) had coexisting AP. AP was most common in the Asian race (66%, p < 0.001). Patients with DKA and AP were older, had higher admission anion-gap, white cell count, hemoglobin (hb), neutrophil/lymphocyte ratio, urea, creatinine, maximum blood glucose during the episode, total cholesterol and triglyceride level (TGL) (p < 0.05). They had a lower admission venous pH and bicarbonate at 6 h. Patients in the DKA with AP group also had a longer length of stay (LOS), DKA duration and a higher rate of ICU admission (p-values ≤ 0.001). In-hospital mortality, 3-month all-cause readmission, 6-month and 12-month DKA recurrence did not differ between the two groups. Univariate logistic regression analysis showed age, Asian ethnicity, male gender, T2D, admission WBC count, hb, urea, creatinine, potassium, venous pH, bicarbonate, anion gap, total cholesterol, TGL and LDL level were significantly associated with the development of DKA with AP (p < 0.05). In multivariate logistic regression analysis, age and total cholesterol level were associated with concomitant DKA and AP (p < 0.05). Patients with concomitant DKA and AP have more severe derangement in markers of DKA severity, inflammation, kidney injury and metabolic profile, along with a longer DKA duration, LOS and requirement for ICU support compared to DKA patients without AP. This highlights the clinical significance of diagnosing the co-existence of DKA with AP, as the combination results in significantly worse clinical outcomes and greater healthcare utilization than in patients with only DKA.
Identifiants
pubmed: 36928586
doi: 10.1038/s41598-023-31465-3
pii: 10.1038/s41598-023-31465-3
pmc: PMC10018622
doi:
Substances chimiques
Bicarbonates
0
Creatinine
AYI8EX34EU
Cholesterol
97C5T2UQ7J
Types de publication
Observational Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4347Informations de copyright
© 2023. The Author(s).
Références
BMJ Case Rep. 2014 Jan 08;2014:
pubmed: 24403385
BMJ Open Diabetes Res Care. 2021 Dec;9(2):
pubmed: 34879999
Diabetologia. 2016 Oct;59(10):2082-7
pubmed: 27397023
Clin Diabetes Endocrinol. 2021 Aug 1;7(1):13
pubmed: 34332631
Reumatol Clin (Engl Ed). 2019 Nov - Dec;15(6):363-367
pubmed: 29274703
J Crit Care. 2002 Mar;17(1):63-7
pubmed: 12040551
BMJ Case Rep. 2021 Apr 19;14(4):
pubmed: 33875498
BMJ Open. 2017 Aug 1;7(7):e016587
pubmed: 28765134
J Transl Med. 2020 May 20;18(1):206
pubmed: 32434518
Am J Mens Health. 2018 Nov;12(6):1958-1965
pubmed: 30095034
Bratisl Lek Listy. 2021;122(7):474-488
pubmed: 34161115
J Int Med Res. 2020 Mar;48(3):300060520912128
pubmed: 32223650
Pancreatology. 2004;4(1):42-8
pubmed: 14988657
Diabetes Care. 2009 Jul;32(7):1335-43
pubmed: 19564476
Lancet Gastroenterol Hepatol. 2016 Sep;1(1):45-55
pubmed: 28404111
Prev Med. 2015 Apr;73:6-9
pubmed: 25602909
J Lab Physicians. 2017 Oct-Dec;9(4):329-331
pubmed: 28966501
Pancreas. 2017 Nov/Dec;46(10):1336-1340
pubmed: 28984788
Pancreas. 2018 Sep;47(8):917-923
pubmed: 30113426
Diabetes Metab Syndr Obes. 2022 Jan 11;15:111-119
pubmed: 35046682
Crit Care Explor. 2021 May 17;3(5):e0444
pubmed: 34036280
BMJ Open Diabetes Res Care. 2020 Mar;8(1):
pubmed: 32139599
Am J Gastroenterol. 2000 Oct;95(10):2795-800
pubmed: 11051350
Front Med (Lausanne). 2022 Mar 17;9:813083
pubmed: 35372444
Diabetes Care. 2009 May;32(5):834-8
pubmed: 19208917
Am Fam Physician. 2022 Jul;106(1):44-50
pubmed: 35839366